Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

March 30, 2018

Primary Completion Date

April 30, 2022

Study Completion Date

May 30, 2022

Conditions
Sickle Cell Crisis
Interventions
DEVICE

Accuvein V400 device

Sickle cell patients who need a new vein puncture in order to infuse them will benefit of AccuveinV400 device to illuminate their venous network

OTHER

Routine procedure

In the control group, the nurse proceeds as usual to infuse the patient (visual identification in the light of the chamber and palpation)

Trial Locations (2)

75908

AP-HP - Hopital Europeen Georges-Pompidou Paris, France, Paris

Unknown

CHU H. Mondor, Créteil

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03477552 - Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID) | Biotech Hunter | Biotech Hunter